These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3814920)

  • 41. Role of 5-ht7 receptors in the long-lasting hypotensive response induced by 5-hydroxytryptamine in the rat.
    Terrón JA
    Br J Pharmacol; 1997 Jun; 121(3):563-71. PubMed ID: 9179401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Actions of 5-hydroxytryptamine and 5-HT1A receptor ligands on rat dorso-lateral septal neurones in vitro.
    Van den Hooff P; Galvan M
    Br J Pharmacol; 1992 Aug; 106(4):893-9. PubMed ID: 1393288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5-Hydroxytryptamine (5-HT) mediates potent relaxation in the sheep isolated pulmonary vein via activation of 5-HT4 receptors.
    Cocks TM; Arnold PJ
    Br J Pharmacol; 1992 Oct; 107(2):591-6. PubMed ID: 1422600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
    Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD
    J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of cholecystokinin (CCK 1) and serotonin (5-HT 3) receptors increases the discharge of pancreatic vagal afferents.
    Mussa BM; Sartor DM; Verberne AJ
    Eur J Pharmacol; 2008 Dec; 601(1-3):198-206. PubMed ID: 19026634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serotonin agonists inhibit synaptic potentials in the rat locus ceruleus in vitro via 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors.
    Bobker DH; Williams JT
    J Pharmacol Exp Ther; 1989 Jul; 250(1):37-43. PubMed ID: 2526217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of temperature upon depolarizing responses of rat isolated vagal nerve to 5-hydroxytryptamine.
    Pike GK; Kerr DI
    Brain Res; 1987 Jun; 413(2):388-91. PubMed ID: 3607489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biguanide derivatives: agonist pharmacology at 5-hydroxytryptamine type 3 receptors in vitro.
    Morain P; Abraham C; Portevin B; De Nanteuil G
    Mol Pharmacol; 1994 Oct; 46(4):732-42. PubMed ID: 7969053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rabbit isolated renal artery contractions by some tryptamine derivatives, including 2-methyl-5-HT, are mediated by a 5-HT1-like receptor.
    Tadipatri S; Feniuk W; Saxena PR
    Br J Pharmacol; 1992 Oct; 107(2):322-8. PubMed ID: 1422584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cisplatin acutely reduces 5-hydroxytryptamine-induced vagal depolarization in the rat: protective action of dexamethasone.
    Woods AJ; Andrews PL
    Eur J Pharmacol; 1995 May; 278(3):275-8. PubMed ID: 7589168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of 5-HT3 receptors in the initiation of pharyngeal reflex.
    Yoshioka M; Goda Y; Ikeda T; Togashi H; Ushiki T; Saito H
    Am J Physiol; 1994 May; 266(5 Pt 2):R1652-8. PubMed ID: 8203646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.
    Buzzi MG; Moskowitz MA; Peroutka SJ; Byun B
    Br J Pharmacol; 1991 Jun; 103(2):1421-8. PubMed ID: 1653072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of 5-hydroxytryptamine on vagal C-fiber subtypes in guinea pig lungs.
    Chuaychoo B; Lee MG; Kollarik M; Undem BJ
    Pulm Pharmacol Ther; 2005; 18(4):269-76. PubMed ID: 15777609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 5-Hydroxytryptamine potentiates neurogenic contractions of rat isolated urinary bladder through both 5-HT(7) and 5-HT(2C) receptors.
    Rekik M; Lluel P; Palea S
    Eur J Pharmacol; 2011 Jan; 650(1):403-10. PubMed ID: 20969855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of the 5-hydroxytryptamine receptor mediating the 'maintained' short-circuit current response in guinea-pig ileal mucosa.
    Scott CM; Bunce KT; Spraggs CF
    Br J Pharmacol; 1992 Aug; 106(4):877-82. PubMed ID: 1393286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
    Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
    Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-Hydroxytryptamine4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus.
    Andrade R; Chaput Y
    J Pharmacol Exp Ther; 1991 Jun; 257(3):930-7. PubMed ID: 2046027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The depolarizing action of 5-hydroxytryptamine on rabbit isolated preganglionic cervical sympathetic nerves.
    Elliott P; Wallis DI
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):608-15. PubMed ID: 3244397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel antagonists of the 5-HT3 receptor. Synthesis and structure-activity relationships of (2-alkoxybenzoyl)ureas.
    Bradley G; Ward TJ; White JC; Coleman J; Taylor A; Rhodes KF
    J Med Chem; 1992 May; 35(9):1515-20. PubMed ID: 1578478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.